Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway

ConclusionsOur findings suggest that breast cancers with loss of p85 α may not respond to mTOR inhibition, but may be sensitive to MEK inhibition.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research